INDAPAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Indapamide patents expire, and when can generic versions of Indapamide launch?
Indapamide is a drug marketed by Actavis Elizabeth, Ani Pharms, Aurobindo Pharma Usa, Chartwell Rx, Rising, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in INDAPAMIDE is indapamide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the indapamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Indapamide
A generic version of INDAPAMIDE was approved as indapamide by ANI PHARMS on July 27th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INDAPAMIDE?
- What are the global sales for INDAPAMIDE?
- What is Average Wholesale Price for INDAPAMIDE?
Summary for INDAPAMIDE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 114 |
| Clinical Trials: | 32 |
| Patent Applications: | 3,937 |
| Drug Prices: | Drug price information for INDAPAMIDE |
| DailyMed Link: | INDAPAMIDE at DailyMed |
Recent Clinical Trials for INDAPAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Bern | Phase 2 |
| Insel Gruppe AG, University Hospital Bern | Phase 2 |
| All India Institute of Medical Sciences, New Delhi | Phase 4 |
Pharmacology for INDAPAMIDE
| Drug Class | Thiazide-like Diuretic |
| Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for INDAPAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for INDAPAMIDE
US Patents and Regulatory Information for INDAPAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | INDAPAMIDE | indapamide | TABLET;ORAL | 074722-001 | Jun 17, 1996 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | INDAPAMIDE | indapamide | TABLET;ORAL | 074585-002 | Sep 26, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | INDAPAMIDE | indapamide | TABLET;ORAL | 074498-001 | Oct 31, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | INDAPAMIDE | indapamide | TABLET;ORAL | 074498-002 | Feb 12, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | INDAPAMIDE | indapamide | TABLET;ORAL | 074594-002 | May 23, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | INDAPAMIDE | indapamide | TABLET;ORAL | 075201-002 | Dec 4, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
